IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Chronic Disease

Specialty medications are used to treat patients with complex and/or rare diseases; have special dosage, storage, handling, and administration requirements; and require high touch patient care and monitoring services (eg, transplant, oncology, MS, hepatitis).

Vabysmo (faricimab-svoa)

,

Vabysmo (faricimab-svoa)

ABYSMO (faricimab-svoa) is a prescription medicine given by injection into the eye used to treat adults with neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO).

Brand Name: Vabysmo (faricimab-svoa)
Generic Name: Vabysmo (faricimab-svoa)
Strength:
Manufacturer:
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Vabysmo (faricimab-svoa)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Vabysmo (faricimab-svoa) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

VANDETANIB Tablets

Vandetanib Tablets for Oral use Initial U.S. Approval: 2011

Name: CAPRELSA
Generic Name: Vandetanib
Strength: Tablets: 100 mg and 300 mg
Manufactured : AstraZeneca Pharmaceuticals LP

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import VANDETANIB Tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

read more

VISTOGARD (uridine triacetate) oral granules

VISTOGARD (uridine triacetate) – emergency treatment of fluorouracil or capecitabine overdose drug therapy in India.

VISTOGARD is a pyrimidine analog indicated for the emergency treatment of adult and pediatric patients:
• following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or
• who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or earlyonset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration.

Brand Name: VISTOGARD
Generic Name: uridine triacetate oral granules
Strength: • Oral granules: 10 gram packets
Manufacturer: Wellstat Therapeutics Corporation
Approved By: USFDA

Source Details: Patient Information.
VISTOGARD must always be used under the supervision of a Registered Medical Practitioner (RMP).

Get Access VISTOGARD for emergency treatment of fluorouracil or capecitabine overdose on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to VISTOGARD (uridine triacetate) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

VIZZ (aceclidine ophthalmic solution)

VIZZ (aceclidine ophthalmic solution) – a presbyopia drug therapy in India.

VIZZ is a cholinergic agonist indicated for the treatment of presbyopia in adults

Brand Name: VIZZ
Generic Name: Aceclidine ophthalmic solution
Strength: • Ophthalmic solution: aceclidine 1.44% in a single-dose vial
Manufacturer: LENZ Therapeutics, Inc.
Approved By: USFDA

Source Details: Patient Information.
VIZZ must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access VIZZ for presbyopia in adults on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to VIZZ (aceclidine ophthalmic solution) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

VUMERITY (diroximel fumarate) delayed-release capsules

VUMERITY (diroximel fumarate) – a multiple sclerosis (MS) drug therapy in India.

VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Brand Name: VUMERITY
Generic Name: Diroximel fumarate delayed-release capsules
Strength: • Delayed-release capsules: 231 mg
Manufacturer: Alkermes
Approved By: USFDA

Source Details: Patient Information.
VUMERITY must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access VUMERITY for multiple sclerosis (MS) on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to VUMERITY (diroximel fumarate) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

VYKAT XR (diazoxide choline) extended-release tablets

VYKAT XR (diazoxide choline) – a Prader-Willi syndrome (PWS) drug therapy in India.

VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS).

Brand Name: VYKAT XR
Generic Name: diazoxide choline extended-release tablets
Strength: • Extended-release tablets: 25 mg, 75 mg, and 150 mg of diazoxide choline.
Manufacturer: Soleno Therapeutics, Inc.
Approved By: USFDA

Source Details: Patient Information.
VYKAT XR must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access VYKAT XR for Prader-Willi syndrome (PWS) on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to VYKAT XR (diazoxide choline) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

WEGOVY (semaglutide) tablets

WEGOVY (semaglutide) – reduced calorie diet and increased physical activity drug therapy in India.

WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity:
• To reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight.
• To reduce excess body weight and maintain weight reduction long term in adults with obesity, or in adults with overweight in the presence of at least one weight-related comorbid condition.

Brand Name: WEGOVY
Generic Name: semaglutide tablets
Strength: • Tablets: 1.5 mg, 4 mg, 9 mg and 25 mg
Manufacturer: Novo Nordisk Inc.
Approved By: USFDA

Source Details: Patient Information.
WEGOVY must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access WEGOVY for adults with established CV disease and either obesity or overweight on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to WEGOVY (semaglutide) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

Xipere (triamcinolone acetonide injectable suspension)

,

Xipere (triamcinolone acetonide)

XIPERE (triamcinolone acetonide injectable suspension) is a corticosteroid used to treat macular edema associated with an eye disease called uveitis.

Brand Name: Xipere
Generic Name: triamcinolone acetonide
Strength:
Manufacturer:
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Xipere (triamcinolone acetonide)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Xipere (triamcinolone acetonide) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

Xphozah (tenapanor)

Xphozah (tenapanor)

XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients.

Brand Name: Xphozah
Generic Name: tenapanor
Strength:
Manufacturer:
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Xphozah (tenapanor)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Xphozah (tenapanor) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in 
urgent@indianpharmanetwork.co.in